Alnylam Pharmaceuticals, Inc. v. Moderna, Inc. et al
Case Number:
1:22-cv-00925
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
August 25, 2023
Alnylam, Moderna Agree To COVID Vax Patent Judgment
Alnylam Pharmaceuticals Inc. and Moderna Inc. on Friday agreed to a final judgment of noninfringement in Alnylam's lawsuit alleging Moderna used patented biotechnology for its Spikevax coronavirus vaccine, following a Delaware federal judge's claim construction ruling, which Alnylam has vowed to appeal.
-
May 12, 2023
Moderna Fires Back At Rival's 'Baseless' Vaccine Patent Row
Drugmaker Moderna has fired back at patent litigation lodged against it by a competitor last year over purportedly poached biotechnology in its coronavirus vaccine known as Spikevax, arguing that the asserted inventions are invalid and the infringement claims can't hold up in light of safe harbor protections.
-
July 12, 2022
Pfizer, Moderna Face New IP Litigation Over COVID Vaccines
Pfizer and Moderna on Tuesday were targeted in another round of patent suits by rival Alnylam Pharmaceuticals over their COVID-19 vaccines, months after Alnylam claimed the vaccines ripped off a different aspect of its "breakthrough" biotechnology in related litigation.